CENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson’s Disease Using Multiomics
January 23, 2024 06:30 ET
|
Centogene NV
CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and...
CENTOGENE Accelerates Global Genetic Data Interpretation, Launching FilterTool Application as Accessory to CentoCloud® Bioinformatics Pipeline
April 26, 2023 08:30 ET
|
Centogene NV
Enabling Rapid and Reliable Diagnosis and Research of Rare Genetic Diseases Around the World CENTOGENE’s FilterTool aims to fuel rapid, reliable analysis for diagnosis and research of rare genetic...
PacBio Collaborates with iLAC and Robotic Biology Institute to Develop Automated Workflows
May 08, 2022 19:00 ET
|
PacBio
MENLO PARK, Calif., TOKYO, May 09, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced a collaboration with...
パックバイオ (PacBio)、iLACおよびロボティック･バイオロジー･インスティテュート株式会社 (Robotic Biology Institute) と共同で自動化ワークフローを開発
May 08, 2022 19:00 ET
|
Pacific Biosciences of California, Inc.
カリフォルニア州メンローパークおよび東京発, May 09, 2022 (GLOBE NEWSWIRE) -- 高品質･高精度のシーケンシングソリューションのリーディングカンパニーであるパックバイオ (PacBio) (NASDAQ: PACB) は、ゲノム解析企業である株式会社アイラック (iLAC, Inc.)、およびロボティック･バイオロジー･インスティテュート株式会社 (Robotic...
PacBio Supports SickKids to Investigate Use of HiFi Sequencing in Undiagnosed Genetic Conditions
February 28, 2022 09:00 ET
|
PacBio
MENLO PARK, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) -- PacBio, a leading provider of high-quality, highly accurate sequencing platforms, today announced it will be supporting The Hospital for Sick...
International Collaborative Study Provides Insight into Gene Activation in One-Cell Embryos
December 28, 2021 03:00 ET
|
Ovation Fertility
Nashville, Tenn., Dec. 28, 2021 (GLOBE NEWSWIRE) -- IVF services company Ovation Fertility announces the publication of a new collaborative study, “Human embryonic genome activation initiates at the...
PacBio and ARUP Laboratories Collaborate in a Study to Improve Rare Disease Diagnosis
November 18, 2021 09:00 ET
|
Pacific Biosciences of California, Inc.
MENLO PARK, Calif., Nov. 18, 2021 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, and ARUP Laboratories announced today they are...
CENTOGENE Initiates EFRONT Study to Identify Patients With Genetic Forms of Frontotemporal Dementia
June 02, 2021 06:31 ET
|
CENTOGENE GmbH
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 02, 2021 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose,...
CENTOGENE Launches NEW CentoXome® - An Enhanced Whole Exome Sequencing Solution
June 01, 2021 06:30 ET
|
CENTOGENE GmbH
World leader and trusted partner in rare diseases releases enhanced Whole Exome Sequencing (WES) solution to improve diagnosis in complex and unsolved patient casesNEW CentoXome® provides...
Ovation Fertility Releases Preliminary Findings of Ongoing Non-Invasive PGT-A Study
February 28, 2021 14:00 ET
|
Ovation Fertility
Los Angeles, Feb. 28, 2021 (GLOBE NEWSWIRE) -- Ovation® Fertility’s Genetics program has released the initial findings of its ongoing study of non-invasive preimplantation genetic testing for...